These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26845400)

  • 41. Neural crest stem cells and their potential therapeutic applications.
    Liu JA; Cheung M
    Dev Biol; 2016 Nov; 419(2):199-216. PubMed ID: 27640086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new immunodeficient retinal dystrophic rat model for transplantation studies using human-derived cells.
    Thomas BB; Zhu D; Lin TC; Kim YC; Seiler MJ; Martinez-Camarillo JC; Lin B; Shad Y; Hinton DR; Humayun MS
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2113-2125. PubMed ID: 30215097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Regenerative medicine for age - related macular degeneration using IPS cells].
    Kurimoto Y
    Nihon Rinsho; 2015 Jun; 73 Suppl 5():442-6. PubMed ID: 30458094
    [No Abstract]   [Full Text] [Related]  

  • 44. Stemming vision loss with stem cells.
    Marchetti V; Krohne TU; Friedlander DF; Friedlander M
    J Clin Invest; 2010 Sep; 120(9):3012-21. PubMed ID: 20811157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC].
    Farge D; Terriou L; Badoglio M; Cras A; Desreumaux P; Hadj-Khelifa S; Marjanovic Z; Moisan A; Dulery R; Faucher C; Hij A; Martin T; Vermersch P; Yakoub-Agha I;
    Pathol Biol (Paris); 2014 Aug; 62(4):204-8. PubMed ID: 25017794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pluripotent stem cells in disease modelling and drug discovery.
    Avior Y; Sagi I; Benvenisty N
    Nat Rev Mol Cell Biol; 2016 Mar; 17(3):170-82. PubMed ID: 26818440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pluripotent Stem Cell-Based Therapies in Combination with Substrate for the Treatment of Age-Related Macular Degeneration.
    Pennington BO; Clegg DO
    J Ocul Pharmacol Ther; 2016 Jun; 32(5):261-71. PubMed ID: 26889704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Preclinical Study of Human Induced Pluripotent Stem Cell-derived Retinal Pigment Epithelium Cell Sheets Transplantation].
    Kamao H
    Nippon Ganka Gakkai Zasshi; 2016 Nov; 120(11):754-63. PubMed ID: 30074740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stem cell-based treatment in geographic atrophy: promises and pitfalls.
    Kvanta A; Grudzinska MK
    Acta Ophthalmol; 2014 Feb; 92(1):21-6. PubMed ID: 23890249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stem Cell Transplantation Procedures Are Becoming Affordable for Individuals Living in Developing (Middle-Income) Countries.
    Ruiz-Argüelles GJ
    Acta Haematol; 2016; 135(2):79-80. PubMed ID: 26512979
    [No Abstract]   [Full Text] [Related]  

  • 51. Bringing the age-related macular degeneration high-risk allele age-related maculopathy susceptibility 2 into focus with stem cell technology.
    Sun S; Li Z; Glencer P; Cai B; Zhang X; Yang J; Li X
    Stem Cell Res Ther; 2017 Jun; 8(1):135. PubMed ID: 28583181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The deadly business of an unregulated global stem cell industry.
    Lysaght T; Lipworth W; Hendl T; Kerridge I; Lee TL; Munsie M; Waldby C; Stewart C
    J Med Ethics; 2017 Nov; 43(11):744-746. PubMed ID: 28356490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell-based therapies for ocular disease.
    Eveleth DD
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):844-54. PubMed ID: 24050306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation.
    Lewandowski J; Kurpisz M
    Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):349-70. PubMed ID: 26939778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stem cell therapy for retinal disease.
    Tibbetts MD; Samuel MA; Chang TS; Ho AC
    Curr Opin Ophthalmol; 2012 May; 23(3):226-34. PubMed ID: 22450217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Degeneration versus Regeneration.
    Koka PS
    J Stem Cells; 2015; 10(3):157-8. PubMed ID: 27125060
    [No Abstract]   [Full Text] [Related]  

  • 58. Microarray analysis reveals retinal stem cell characteristics of the adult human eye. For contributed volumes.
    Angénieux B; Michaut L; Schorderet DE; Munier FL; Gehring W; Arsenijevic Y
    Adv Exp Med Biol; 2006; 572():377-80. PubMed ID: 17249599
    [No Abstract]   [Full Text] [Related]  

  • 59. Human pluripotent stem cell strategies for age-related macular degeneration.
    Davidson KC; Guymer RH; Pera MF; Pébay A
    Optom Vis Sci; 2014 Aug; 91(8):887-93. PubMed ID: 24859130
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Stem cell therapy of the eye].
    Skottman H; Uusitalo EH
    Duodecim; 2014; 130(19):1991-9. PubMed ID: 25558620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.